In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples